Czechia – Antineoplastic agents – Cytostatikum, inhibitor tyrozinkináz s účinnou látkou Crizotinibum
openFakultní nemocnice Ostrava · 00843989
Value
CZK 8.0m
Published
13 Nov 2026
Deadline
15 Dec 2026, 10:00 GMT · 32d left · as published, verify on the notice
Type
opportunity
33652100 · Medical equipment, pharmaceuticals & personal careCZ080CZ052
Description
Předmětem plnění veřejné zakázky jsou průběžné a opakované dodávky léčivého přípravku „Cytostatikum, inhibitor tyrozinkináz s účinnou látkou Crizotinibum o silách 200 mg a 250 mg v 1 tvrdé tobolce (dále společně jen „LP“), v souladu s touto ZD a jejími přílohami.
Key facts
- Procedure
- open
- Contact
- nadezda.adamkova@fno.cz
- Regime
- publicSector
- Category
- supplies
What a subscription adds to this notice
- The documents — every attachment, with its text extracted and searchable
- Qualification — the notice scored against your company profile
- Tracking and alerts — a pipeline for your bids, and the matching notices by email
- Calendar export — the deadline as a calendar file
- The API and MCP — the same record in your own tools and your AI assistant
Provenance
- Source
- ted-eu
- Notice id
- 790827-2026
- First seen
- 13 Nov 2026
- Last updated
- 13 Nov 2026
Licence EU reuse — Commission Decision 2011/833/EU ↗
Source: TED — Tenders Electronic Daily (ted.europa.eu), © European Union, reused under Commission Decision 2011/833/EU.
View at source ↗
GET /api/v1/tenders/3c1ee8b8-6491-4a2e-986e-a06135a77acaThe source notice is authoritative — verify deadlines and documents there before bidding.